HOME >> BIOLOGY >> NEWS
Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

ed States Representative (N.Y.)

  • The Honorable Joseph L. Bruno, New York State Senate Majority Leader

  • The Honorable Elias Zerhouni, M.D., Director, National Institutes of Health

  • Bruce Alberts, Ph.D. President, National Academy of Sciences

  • Samuel Heffner Jr. '56, Chairman, Board of Trustees, Rensselaer Polytechnic Institute

  • Howard P. Isermann '42, Honorary Trustee, Rensselaer Polytechnic Institute

  • Robert E. Palazzo, Ph.D., Acting Director, Center for Biotechnology and Interdisciplinary Studies and Chair, Department of Biology, Rensselaer Polytechnic Institute

    "This extraordinary group of leaders in the sciences, engineering, business and government is rarely assembled in one place, and their participation is a testament to what the Rensselaer community has accomplished in a few short years," said Rensselaer President Shirley Ann Jackson. "By establishing the Center for Biotechnology and Interdisciplinary Studies, we have created a gathering place where scientists and engineers from various disciplines will explore at the intersection of the life sciences, with engineering and the physical and information sciences, thereby accelerating discovery and ultimately enhancing the quality of life for all people."

    Rensselaer's new center ranks among the world's most advanced research facilities focused on the application of engineering and the physical and information sciences to the life sciences. The Center for Biotechnology and Interdisciplinary Studies is a 218,000-square-foot, $100 million facility (including $80 million for construction). With its high-tech laboratories and expansive atrium, it provides a platform for collaboration among many diverse academic and research disciplines to enhance discovery and encourage innovation.

    The Center is designed to foster the multidisciplinary nature of biotechnology. It is organized around "constellations" of research Biocomputation and Bioin
    '"/>



  • Contact: Theresa Bourgeois
    bourgt@rpi.edu
    518-276-2840
    Rensselaer Polytechnic Institute
    2-Sep-2004


    Page: 1 2 3 4

    Related biology news :

    1. Rensselaer receives NIH grant to develop virtual surgery simulator
    2. New software developed at Rensselaer predicts promising ingredients for new drugs
    3. Rensselaer awarded $2.7 million NIH grant to improve drug development process
    4. National Institutes of Health grant to Rensselaer to further research on healing bone injuries
    5. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
    6. Rensselaer effort to pull mussels at Lake George looks promising
    7. NASA Funds New Origin Of Life Center at Rensselaer Polytechnic Institute
    8. X marks the spot: Vector insertion is viral specific
    9. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
    10. High Flux Isotope Reactor marks 400th cycle
    11. Study marks increased trends in infectious disease occurrences in our oceans

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
    (Date:1/30/2017)... , Jan. 30, 2017   Invitae Corporation ... growing genetic information companies, today announced that it will ... and provide 2017 guidance on Monday, February 13, 2017, ... that day at 4:45 p.m. Eastern / 1:45 p.m. ... team will briefly review financial results, guidance, and recent ...
    (Date:1/24/2017)...  It sounds simple and harmless—an electronic sensor ... signs and alerts parents on their smart phones ... drops. But pediatric experts argue that such devices ... evidence of medical benefits, especially to healthy babies. ... parents of healthy babies, promising peace of mind ...
    Breaking Biology News(10 mins):
    (Date:2/23/2017)... SAN DIEGO and SAN FRANCISCO ... , a privately-held regenerative medicine company, and Beyond Type ... living with type 1 diabetes, today announced a grant ... develop a functional cure for type 1 and other ... decade, ViaCyte has been developing innovative stem cell-derived cell ...
    (Date:2/22/2017)... ... 22, 2017 , ... Kernel , a human intelligence ... (KRS) clinical development program. KRS is a neurotechnology spin-out from the Massachusetts ... applications. The terms of the transaction were not disclosed. , It addition ...
    (Date:2/22/2017)... Feb. 22, 2017 Scientists propose in ... organ damage in Gaucher and maybe other lysosomal storage ... lower costs than current therapies. An international ... Center , which also included investigators from the University ... their data Feb. 22. The study was conducted in ...
    (Date:2/22/2017)... ... February 22, 2017 , ... LabRoots ... scientists from around the world, is pleased to announce the 2nd annual Precision ... 2017. This premier, online-only conference focused on the development and advancements in precision ...
    Breaking Biology Technology:
    Cached News: